KEGG   DRUG: Cosfroviximab
Entry
D10919                      Drug                                   
Name
Cosfroviximab (USAN/INN)
Sequence
(Heavy chain)
DVKLLESGGG LVQPGGSLKL SCAASGFSLS TSGVGVGWFR QPSGKGLEWL ALIWWDDDKY
YNPSLKSQLS ISKDFSRNQV FLKISNVDIA DTATYYCARR DPFGYDNAMG YWGQGTSVTV
SSASTKGPSV FPLAPSSKST SGGTAALGCL VKDYFPEPVT VSWNSGALTS GVHTFPAVLQ
SSGLYSLSSV VTVPSSSLGT QTYICNVNHK PSNTKVDKRV EPKSCDKTHT CPPCPAPELL
GGPSVFLFPP KPKDTLMISR TPEVTCVVVD VSHEDPEVKF NWYVDGVEVH NAKTKPREEQ
YNSTYRVVSV LTVLHQDWLN GKEYKCKVSN KALPAPIEKT ISKAKGQPRE PQVYTLPPSR
DELTKNQVSL TCLVKGFYPS DIAVEWESNG QPENNYKTTP PVLDSDGSFF LYSKLTVDKS
RWQQGNVFSC SVMHEALHNH YTQKSLSLSP GK
(Light chain)
DIVMTQSPLS LSTSVGDRVS LTCKASQNVG TAVAWYQQKP GQSPKLLIYS ASNRYTGVPD
RFTGSGSGTD FTLTISNMQS EDLADYFCQQ YSSYPLTFGA GTKLELRTVA APSVFIFPPS
DEQLKSGTAS VVCLLNNFYP REAKVQWKVD NALQSGNSQE SVTEQDSKDS TYSLSSTLTL
SKADYEKHKV YACEVTHQGL SSPVTKSFNR GEC
(Disulfide bridge: H22-H97, H149-H205, H225-L213, H231-H'231, H234-H'234, H266-H326, H372-H430, H'22-H'97, H'149-H'205, H'225-L'213, H'266-H'326, H'372-H'430, L23-L88, L133-L193, L'23-L'88, L'133-L'193)
  Type
Peptide
Efficacy
Antiviral
  Type
Monoclonal antibody
Comment
Treatment of Ebola virus
Target
Ebolavirus envelope glycoprotein [KO:K24534]
  Pathway
ko03230  Viral genome structure
Brite
Antimicrobials [BR:br08307]
 Antivirals
  Entry, fusion or uncoating inhibitor
   Ebolavirus glycoprotein
    D10919  Cosfroviximab (USAN/INN)
Other DBs
CAS: 1792982-57-0
PubChem: 342581776
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system